FDA names Barclay Butler COO
Plus: Scott Gottlieb named chair of Illumina, and updates from Syncromune and OSR
Barclay Butler was named deputy commissioner for operations and chief operating officer in the office of operations at FDA. Butler held various roles at the Defense Health Agency, including as assistant director for support, management and healthcare administration. He was most recently an independent consultant at Barclay Consulting Services.
DNA sequencing company Illumina Inc. (NASDAQ:ILMN) named Scott Gottlieb chair of the board. Gottlieb served as 23rd commissioner of FDA from 2017 to 2019 and joined Illumina’s board in 2020. He is a partner at New Enterprise Associates and a senior fellow at the American Enterprise Institute. Additionally, Stephen MacMillan will retire from the board, while Keith Meister will become a board member on March 28...